Skip to main content

Roche’s First Quarter Sales 2026 Presentation

Roche has published its First Quarter Sales for 2026 prior to the opening of the Swiss Stock Exchange on Thursday, 23rd April 2026.

Agenda
Agenda
OverviewThomas Schinecker, CEO Roche Group
Financial ResultsAlan Hippe, Chief Financial Officer
Pharmaceuticals DivisionTeresa Graham, CEO Roche Pharmaceuticals
Diagnostics DivisionMatt Sause, CEO Roche Diagnostics
Q&ABruno Eschli, Head of Investor Relations

Webinar Replay

Please click the video below to watch the replay of the webinar.

Investors

Past IR Events
View more Events